Compound Search
Compound Database
Powered by a PubChem CID-based index. Search by name, synonym, CAS number, or SMILES.
-
F (EP); Rabeprazole USP Related Compound C; Rabeprazole USP RC C; 1,3-Dihydro-2H-benzimidazole-2-thione CAS 583-39-1 PubChem CID 707035
S=c1[nH]c2ccccc2[nH]1 -
FC(F)Oc1ccc2[nH]c(=S)[nH]c2c1 -
C (EP); Lansoprazole USP Related Compound B; Lansoprazole USP RC B; 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy CAS 103577-40-8 PubChem CID 1094080
Cc1c(OCC(F)(F)F)ccnc1CSc1nc2ccccc2[nH]1 -
5-[Bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic Acid Ethyl Ester; [1-Methyl-5-bis(2 CAS 3543-74-6 PubChem CID 13086945
CCOC(=O)CCCc1nc2cc(N(CCO)CCO)ccc2n1C -
2-Ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylic Acid; Candesartan Cilexetil Imp. G (EP); Candesartan Cilexetil USP Related Compound G; Candesartan Cilexetil USP RC G; Candesartan; Candesartan Cilexetil Related Compound G; Candesartan Cilexetil Impurity G CAS 139481-59-7 PubChem CID 2541
CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1 -
Lansoprazole Imp. F (EP); Rabeprazole Sodium Imp. H (EP); Rabeprazole Imp. H (EP); Rabeprazole USP Related Compound F; Rabeprazole USP RC F; 2-[(RS)-[(4-Chloro-3-methylpyridin-2-yl)methyl]sulphinyl]-1H-benzimidazole; Rabeprazole Related Compound F; Lansoprazole Impurity F; Rabeprazole Sodium Impurity H; Rabeprazole Impurity H CAS 168167-42-8 PubChem CID 11335757
Cc1c(Cl)ccnc1CS(=O)c1nc2ccccc2[nH]1 -
Mebendazole Imp. C (EP); (2-Amino-1-methyl-1H-benzimidazol-5-yl)phenylmethanone; Mebendazole Related Compound C; Mebendazole Impurity C CAS 66066-76-0 PubChem CID 69450787
Cn1c(N)nc2cc(C(=O)c3ccccc3)ccc21 -
1-[(4-Chlorophenyl)methyl]-2-[(pyrrolidin-1-yl)methyl]-1H-1,3-benzimidazole CAS 442-52-4 PubChem CID 2782
Clc1ccc(Cn2c(CN3CCCC3)nc3ccccc32)cc1 -
2-Aminobenzimidazole; 1H-Benzimidazol-2-amine; Benzimidazole, 2-amino- (6CI,7CI,8CI); 1H-Benzimidazol-2-ylamine; 2-AB; 2-Amino-1H-benzimidazole; 2-Aminobenzimidazole; 2-Benzimidazolamine; 2-Benzimidazolylamine; 2-Iminobenzimidazoline; NSC 27793; NSC 7628 CAS 934-32-7 PubChem CID 13624
Nc1nc2ccccc2[nH]1 -
ss-Alanine, N-[[2-[[[4-[[[(hexyloxy)carbonyl]amino]carbonyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester; ethyl N-[(2-{[(4-{[(hexyloxy)carbonyl]carbamoyl}phenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl) carbonyl]-N-pyridin-2-yl-ss-alaninate; Dabigatran Etexilate Amid Analogon CAS 1408238-40-3 PubChem CID 70968095
CCCCCCOC(=O)NC(=O)c1ccc(NCc2nc3cc(C(=O)N(CCC(=O)OCC)c4ccccn4)ccc3n2C)cc1 -
C-3742|||2-[4-(4-chlorophenoxy)phenyl]-3H-benzimidazole-5-carboxamide CAS 516480-79-8 PubChem CID 9969021
NC(=O)c1ccc2nc(-c3ccc(Oc4ccc(Cl)cc4)cc3)[nH]c2c1 -
Dabigatran intermediate;Alanine, N-[[2-[[[4-(aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester CAS 429658-95-7 PubChem CID 446804
CCOC(=O)CCN(C(=O)c1ccc2c(c1)nc(CNc1ccc(C(=N)N)cc1)n2C)c1ccccn1 -
(2E)-3-[4-({[1-({[1-Cyclohexyl-2-(3-furyl)-1H-benzimidazol-5-yl]carbonyl}amino)cyclobutyl]carbonyl}amino)phenyl]acrylic acid PubChem CID 6479965
O=C(O)/C=C/c1ccc(NC(=O)C2(NC(=O)c3ccc4c(c3)nc(-c3ccoc3)n4C3CCCCC3)CCC2)cc1 -
O-(2-Ethylbutyl) Dabigatran Ethyl Ester; ss-Alanine, N-[[2-[[[4-[[[(2-ethylbutoxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester (ACI); N-[[2-[[[4-[[[(2-Ethylbutoxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-ben CAS 1610758-20-7 PubChem CID 135741695
CCOC(=O)CCN(C(=O)c1ccc2c(c1)nc(CNc1ccc(C(=N)NC(=O)OCC(CC)CC)cc1)n2C)c1ccccn1 -
Bilastine 2-(2-Methylpropanol)amide; 2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)-N-(1-hydroxy-2-methylpropan-2-yl)-2-methylpropanamide CAS 2767509-00-0 PubChem CID 162788048
CCOCCn1c(C2CCN(CCc3ccc(C(C)(C)C(=O)NC(C)(C)CO)cc3)CC2)nc2ccccc21